Anzeige
Mehr »
Donnerstag, 16.10.2025 - Börsentäglich über 12.000 News
Milliardär-gestützt: Eine 10-Bagger-Goldaktie, die gerade erst durchstartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
317 Leser
Artikel bewerten:
(1)

EndoQuest Robotics Announces Appointment of Dr. Todd Wilson as Chief Medical Officer

HOUSTON, TX / ACCESSWIRE / January 25, 2023 / EndoQuest Robotics today announced that Dr. Todd Wilson has joined the company as Chief Medical Officer. In this role, Dr. Wilson will lead EndoQuest's expanding focus on development of the company's proprietary Endoluminal Surgical (ELS) System, the world's first flexible endoluminal robotic surgical system that makes it possible for therapeutic endoscopists and surgeons to perform upper and lower gastrointestinal surgery less-invasively through a trans-oral or trans-anal approach.

EndoQuest Robotics, Wednesday, January 25, 2023, Press release picture

"We are very pleased to welcome Dr. Wilson to the EndoQuest team. His extensive experience in minimally invasive robotic surgery will be a critical asset to us as we develop the next phase of our proprietary ELS System," said Kurt Azarbarzin, Chief Executive Officer of EndoQuest Robotics. "As a highly experienced robotic surgeon, he can provide critical peer-to-peer insight that can reinforce the rigor of our clinical research and the advantages of our technology."

Dr. Wilson is a minimally invasive and robotic surgeon and associate professor at The University of Texas Medical School at Houston, John P. and Kathrine G. McGovern Medical School. His surgical practice focuses on stomach and esophageal disease with an emphasis on developing, teaching, and validating procedures for robotic and endoluminal surgery. He has over 70 peer reviewed published articles, is continuously involved in trials related to robotics and endoluminal techniques, and as the medical director of the Surgical Innovation and Robotics Institute has helped to train thousands of surgeons from all over the world in robotic surgery. Prior to medical school, Todd was a Surface Warfare Officer during which he served three tours as an engineer, as an operations officer and finally as an admiral's aide. He is excited to help bring EndoQuest's technology to physicians and to see its impact on medical therapies.

"I am very excited to be joining the team at EndoQuest at this pivotal time in the development of the company's innovative ELS System," said Dr. Wilson. "This technology is designed to offer endoscopists and surgeons new levels of access, control and precision in endoluminal surgeries and help improve outcomes for patients in a range of procedures in the years ahead."

About EndoQuest Robotics

EndoQuest Robotics is developing the Endoluminal Surgical (ELS) System, the world's first flexible endoluminal robotic surgical system, to provide therapeutic endoscopists and surgeons the ability to perform upper and lower gastrointestinal surgery less-invasively through a trans-oral or trans-anal approach. EndoQuest's robotic platform combines the flexibility of endoscopy that can navigate the curvature of patients' anatomy with instrumentation that allows the physician to use a conventional two-handed surgical technique. The EndoQuest ELS System will have further potential applications in a range of minimally invasive surgeries including appendectomy and cholecystectomy that can be performed with no external incisions. For additional information, visit www.endoquestrobotics.com.

EndoQuest's ELS System is under development, has not been cleared by the U.S. Food and Drug Administration (FDA) and is not for commercial sale in the United?States.

Company Contact

Chris Klecher
chris.klecher@endoquestrobotics.com
949.310.8271

SOURCE: EndoQuest Robotics

View source version on accesswire.com:
https://www.accesswire.com/736277/EndoQuest-Robotics-Announces-Appointment-of-Dr-Todd-Wilson-as-Chief-Medical-Officer

© 2023 ACCESS Newswire
Solarbranche vor dem Mega-Comeback?
Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:
  • Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
  • Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
  • hina bremst Preisdumping & pusht massiv den Ausbau
Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.